Veterinary Medicines

PARVOERYSIN

Authorised
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, Inactivated
Download as PDF

Product identification

Medicine name:
PARVOERYSIN
Active substance:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 1, Inactivated
Target species:
  • Pig (sow)
  • Pig (male)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 1, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow)
      • Meat and offal
        0
        day
    • Pig (male)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 140149
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 20/12/2021
Download